Fig. 1: A flowchart diagram summarising the investigation pathway of 65 study participants with a new diagnosis of neovascular age-related macular degeneration (AMD). | Eye

Fig. 1: A flowchart diagram summarising the investigation pathway of 65 study participants with a new diagnosis of neovascular age-related macular degeneration (AMD).

From: The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD

Fig. 1: A flowchart diagram summarising the investigation pathway of 65 study participants with a new diagnosis of neovascular age-related macular degeneration (AMD).The alternative text for this image may have been generated using AI.

Peripheral blood samples were taken at seven visits (baseline visit and six follow-up visits), for serum and genotypic analysis.

Back to article page